Post-Market Registry Study for Vibrant Hearing Solutions
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- MED-EL Elektromedizinische Geräte GmbH
- Trial code
- NCT07906314
- Record updated
- 4 November 2026
- Original description
This observational registry collects retrospective and prospective, data from children and adults who use CE-marked MED-EL implantable (PMEI, BCI, or AMEI) or non-implantable (BCD) hearing solutions as part of routine care. Participants will be followed long term, potentially up to the lifetime of their hearing solution, to assess quality of life, hearing and speech performance, and device use. Data will be collected using routinely administered clinical tests and questionnaires to evaluate real-world outcomes across diverse populations and MED-EL hearing systems.Read full original descriptionShow less
This observational registry collects retrospective and prospective, data from children and adults who use CE-marked MED-EL implantable (PMEI, BCI, or AMEI) or non-implantable (BCD) hearing solutions as part of routine care. Participants will be followed long term, potentially up to the lifetime of their hearing solution, to assess quality of life, hearing and speech performance, and device use. Data will be collected using routinely administered clinical tests and questionnaires to evaluate real-world outcomes across diverse populations and MED-EL hearing systems.
Inclusion: Adults (18 years or older) and children already treated or in the case a treatment is planned with a CE marked MED-EL Hearing Solution in the respective indication criteria; Signed and dated informed consent before the start of any registry- specific procedure and collection of any data; Ability to respond to self-administered rating scales or ability of the parent/legal guardian to respond as a proxy to questionnaires for users of MED-EL hearing solutions unable to do so.
Exclusion: Lack of compliance with any inclusion criteria; Hearing solutions without CE-Mark or that are no longer marketed; Hearing solutions with initial market entry exceeding 10 years at time of enrolment; Anything that, in the opinion of the Investigator would place the participant at increased risk or preclude the participant's full compliance with or completion of the registry procedures.